Crossmark

[Translated article] Influence of SARS-CoV-2 infection on the use of ceftazidime-avibactam in the critical patient

Crossref DOI link: https://doi.org/10.1016/j.farma.2025.03.016

Published Print: 2025-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Mayo Olveira, Fátima

Caro Teller, José Manuel

Canales Siguero, María Dolores

Ortiz Pérez, Sara

Jiménez León, María del Carmen

Ferrari Piquero, José Miguel
License Information

Text and Data Mining valid from 2025-11-01

Text and Data Mining valid from 2025-11-01

Version of Record valid from 2025-03-29
More Information

This article is maintained by: Elsevier

Article Title: [Translated article] Influence of SARS-CoV-2 infection on the use of ceftazidime-avibactam in the critical patient

Journal Title: Farmacia Hospitalaria

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.farma.2025.03.016

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.farma.2024.10.018

Content Type: article

Copyright: © 2024 Sociedad Española de Farmacia Hospitalaria (S.E.F.H). Published by Elsevier España, S.L.U.